Given the differences in assay platform, time, location, and dosage between the four experiments, it is encouraging to find shared genes that are relevant biologically; EGFR, CDK6, and CDC20 play key functions in cell cycle progression and have been implicated in bladder cancer [55–57]. Here, EGFR is linked to urinary bladder carcinoma.